We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TLIS market cap is 16.23M. The company's latest EPS is USD -34.0487 and P/E is -0.26.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.22M | 581k | 140k | 195k | 73k |
| Operating Income | -19M | -16.39M | -16.97M | -11.69M | -10.22M |
| Net Income | -17.83M | -15.03M | -15.68M | -13.46M | -13.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.98M | 10.94M | 8.19M | 4.81M | 2.13M |
| Operating Income | -26.7M | -91.18M | -191.82M | -111.55M | -64.05M |
| Net Income | -27.47M | -91.13M | -192.04M | -113.01M | -62.01M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 133.05M | 123.08M | 107.23M | 94.67M | 82.49M |
| Total Liabilities | 22.93M | 26.91M | 25.67M | 25.56M | 25.81M |
| Total Equity | 110.12M | 96.17M | 81.56M | 69.12M | 56.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.73M | 198.41M | 265.83M | 169.29M | 94.67M |
| Total Liabilities | 4.12M | 16.03M | 31.85M | 42.55M | 25.56M |
| Total Equity | -21.14M | -108.57M | 233.98M | 126.74M | 69.12M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.47M | -30.74M | -41.88M | -53.24M | -6.43M |
| Investing | -24k | -509k | -579k | -486k | 30k |
| Financing | 33k | 33k | 33k | 33k | 2k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.33M | -87.02M | -171.38M | -100.14M | -53.24M |
| Investing | -578k | -8.2M | -2.87M | -1.62M | -486k |
| Financing | 39.61M | 246.75M | 234.43M | 406k | 33k |
| Market Cap | 16.23M |
| Price to Earnings Ratio | -0.26 |
| Price to Sales Ratio | 7.6 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.23 |
| Dividend Yield | - |
| Shares Outstanding | 1.82M |
| Average Volume (1 week) | 4.12k |
| Average Volume (1 Month) | 5.76k |
| 52 Week Change | 19.33% |
| 52 Week High | 9.60 |
| 52 Week Low | 4.35 |
| Spread (Intraday) | 2.06 (19.06%) |
| Company Name | Talis Biomedical Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://talisbio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
